EUVIMEDEUVIMED entdecken
Crossref

Clinical characteristics and outcomes of secondary orbital lymphoma

Trisha Yc Pecoraro iD, Kenny Y Wang iD, B Michelle Kim iD, Grant M Welk iD, Robert A Churchill iD, Andrea A Tooley iD, Lauren A Dalvin iD

European Journal of Ophthalmology · 2026

DOI: 10.1177/11206721261452074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Ophthalmology, 2026. Verfasst von Trisha Yc Pecoraro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Orbital Neoplasms, Lymphoma. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Division of Cancer Prevention, National Cancer Institute, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To investigate the clinical features, treatments, and outcomes of patients with secondary orbital lymphoma. Major Findings In this cohort of 31 patients, 15 (48.4%) were female and 27 (87.1%) were white. Follicular lymphoma was the most common subtype (n = 13, 41.9%) and was more associated with unilateral disease compared to other subtypes (p = 0.01). Common presenting symptoms included a palpable mass (n = 17, 54.8%), eyelid swelling (n = 16, 51.6%), and ptosis (n = 12, 38.7%). Patients were most often diagnosed with Ann Arbor Stage IV lymphoma (n = 17, 54.8%) via incisional biopsy (n = 13, 41.9%). Radiation therapy (n = 9, 29.0%) was the most common initial treatment, and most patients received radiation (n = 19, 61.3%) and/or chemotherapy (n = 21, 67.7%). A majority of patients had final best corrected visual acuity (BCVA) within 1 line of initial BCVA (n = 19, 82.6%) and had no local recurrences (n = 21, 67.7%). However, complete remission was rare (n = 3, 9.7%), and systemic recurrence occurred in over half of patients (n = 18, 58.1%).

Conclusions

Follicular lymphoma was the predominant subtype of secondary orbital lymphoma in this cohort. Most patients with secondary orbital lymphoma presented with advanced disease where few achieved complete remission and more than half of the patients developed systemic recurrence despite majority retaining visual acuity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Orbital NeoplasmsLymphomaHumansFemaleMaleMiddle AgedRetrospective StudiesAgedAdultVisual AcuityAged, 80 and overNeoplasm StagingTreatment OutcomeTomography, X-Ray ComputedBiopsyCombined Modality Therapy

Stichwörter der Autor:innen

Secondaryorbital lymphomaorbital neoplasmorbital tumor

Autor:innen und Institutionen

  • Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: Trisha Yc Pecoraro, Kenny Y Wang, B Michelle Kim, Grant M Welk, Robert A Churchill, Andrea A Tooley, Lauren A Dalvin

Förderung

  • Division of Cancer Prevention, National Cancer Institute
  • National Center for Advancing Translational Sciences

Zitieren

APA

Pecoraro, T. Y., Wang, K. Y., Kim, B. M., Welk, G. M., Churchill, R. A., Tooley, A. A., & Dalvin, L. A. (2026). Clinical characteristics and outcomes of secondary orbital lymphoma. European Journal of Ophthalmology. https://doi.org/10.1177/11206721261452074

Vancouver

Pecoraro TY, Wang KY, Kim BM, Welk GM, Churchill RA, Tooley AA, et al. Clinical characteristics and outcomes of secondary orbital lymphoma. European Journal of Ophthalmology. 2026. doi:10.1177/11206721261452074

BibTeX
@article{Pecoraro2026,
  author = {Pecoraro, Trisha Yc and Wang, Kenny Y and Kim, B Michelle and Welk, Grant M and Churchill, Robert A and Tooley, Andrea A and Dalvin, Lauren A},
  title = {Clinical characteristics and outcomes of secondary orbital lymphoma},
  journal = {European Journal of Ophthalmology},
  year = {2026},
  doi = {10.1177/11206721261452074}
}
Kostenlos starten →